Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $19,250 | 8 | 58.6% |
| Food and Beverage | $7,390 | 359 | 22.5% |
| Travel and Lodging | $4,896 | 24 | 14.9% |
| Honoraria | $1,300 | 1 | 4.0% |
| Education | $33.08 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Kaleo, Inc. | $25,208 | 84 | $0 (2019) |
| ARBOR PHARMACEUTICALS, INC. | $1,403 | 6 | $0 (2021) |
| Boston Scientific Corporation | $1,268 | 31 | $0 (2024) |
| Nevro Corp. | $712.22 | 18 | $0 (2024) |
| PFIZER INC. | $443.26 | 31 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $424.86 | 31 | $0 (2024) |
| Allergan, Inc. | $386.70 | 26 | $0 (2021) |
| Amgen Inc. | $352.57 | 7 | $0 (2020) |
| Abbott Laboratories | $289.76 | 9 | $0 (2024) |
| Purdue Pharma L.P. | $267.23 | 29 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,024 | 41 | Nevro Corp. ($431.27) |
| 2023 | $774.42 | 26 | Medtronic, Inc. ($245.80) |
| 2022 | $96.91 | 5 | Boston Scientific Corporation ($39.91) |
| 2021 | $598.70 | 18 | BOSTON SCIENTIFIC CORPORATION ($386.10) |
| 2020 | $853.44 | 44 | Boston Scientific Corporation ($195.39) |
| 2019 | $10,228 | 53 | Kaleo, Inc. ($9,626) |
| 2018 | $17,683 | 90 | Kaleo, Inc. ($15,362) |
| 2017 | $1,611 | 117 | Purdue Pharma L.P. ($231.53) |
All Payment Transactions
394 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.30 | General |
| Category: Opioid Analgesic | ||||||
| 12/18/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $29.89 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/12/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/11/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $42.54 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/02/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Neuromodulation | ||||||
| 11/14/2024 | SPR Therapeutics, Inc | SPRINT PNS System (Device) | Food and Beverage | Cash or cash equivalent | $18.33 | General |
| Category: Pain management | ||||||
| 11/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Neuromodulation | ||||||
| 11/05/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Neuromodulation | ||||||
| 11/04/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $35.21 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/01/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Opioid Analgesic | ||||||
| 11/01/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Opioid Analgesic | ||||||
| 11/01/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/30/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/24/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $7.43 | General |
| Category: Opioid Analgesic | ||||||
| 10/08/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $131.08 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/20/2024 | Fidia Pharma USA Inc. | HYMOVIS (Device), HYALGAN, TRILURON | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: OSTEOARTHRITIS | ||||||
| 09/18/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $112.15 | General |
| Category: Spinal Cord Stimulator | ||||||
| 09/16/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Opioid Analgesic | ||||||
| 09/16/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $18.50 | General |
| Category: Opioid Analgesic | ||||||
| 09/12/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Spinal Cord Stimulator | ||||||
| 08/26/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.09 | General |
| Category: Opioid Analgesic | ||||||
| 08/20/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $8.18 | General |
| Category: Opioid Analgesic | ||||||
| 06/25/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $6.23 | General |
| Category: Opioid Analgesic | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 158 | 266 | $107,870 | $20,036 |
| 2022 | 4 | 185 | 1,352 | $105,074 | $39,018 |
| 2021 | 4 | 196 | 1,276 | $244,630 | $55,851 |
| 2020 | 9 | 289 | 1,917 | $396,007 | $71,431 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 175 | $78,750 | $13,862 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 91 | $29,120 | $6,174 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 352 | $57,111 | $33,810 | 59.2% |
| 00142 | Anesthesia for lens surgery | Facility | 2022 | 35 | 37 | $24,354 | $3,000 | 12.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 43 | 61 | $7,604 | $2,132 | 28.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 27 | 902 | $16,005 | $76.98 | 0.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 81 | 497 | $130,781 | $33,224 | 25.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 67 | 187 | $63,497 | $19,589 | 30.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $14,828 | $2,983 | 20.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 26 | 570 | $35,524 | $55.94 | 0.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 105 | 735 | $327,810 | $58,636 | 17.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 40 | 40 | $26,960 | $4,381 | 16.2% |
| 64493 | Injections of lower or sacral spine facet joint using imaging guidance | Office | 2020 | 15 | 21 | $15,057 | $3,334 | 22.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 39 | $11,856 | $2,160 | 18.2% |
| 64494 | Injections of lower or sacral spine facet joint using imaging guidance | Office | 2020 | 14 | 20 | $7,377 | $1,593 | 21.6% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Office | 2020 | 15 | 18 | $2,880 | $751.61 | 26.1% |
| 99422 | Online digital evaluation and management service, for an established patient, for up to 7 days, cumulative time during the 7 days; 11-20 minutes | Office | 2020 | 13 | 13 | $2,293 | $312.55 | 13.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2020 | 22 | 160 | $1,600 | $179.77 | 11.2% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2020 | 30 | 871 | $174.20 | $84.12 | 48.3% |
About Dr. Rasheed Singleton, MD
Dr. Rasheed Singleton, MD is a Pain Medicine healthcare provider based in Conyers, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1316924558.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Rasheed Singleton, MD has received a total of $32,869 in payments from pharmaceutical and medical device companies, with $1,024 received in 2024. These payments were reported across 394 transactions from 43 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($19,250).
As a Medicare-enrolled provider, Singleton has provided services to 828 Medicare beneficiaries, totaling 4,811 services with total Medicare billing of $186,337. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Other Specialties Interventional Pain Medicine
- Location Conyers, GA
- Active Since 12/29/2005
- Last Updated 01/10/2024
- Taxonomy Code 208VP0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1316924558
Products in Payments
- Evzio (Drug) $15,582
- EVZIO (Drug) $9,626
- Horizant (Drug) $1,403
- Senza (Device) $431.27
- LYRICA (Drug) $283.15
- Senza Spinal Cord Stimulation System (Device) $280.95
- BOTOX (Biological) $256.11
- WAVEWRITER ALPHA (Device) $250.22
- SPECTRA WAVEWRITER (Device) $222.19
- XTAMPZA (Drug) $217.48
- Aimovig (Biological) $214.29
- RELISTOR (Drug) $176.63
- LORZONE (Drug) $172.48
- SPECTRA SYSTEM (Device) $170.50
- WaveWriter Alpha Prime 16 (Device) $164.72
- SCS leads (Device) $139.80
- Belbuca (Drug) $136.39
- SYNCHROMEDII (Device) $133.89
- BUNAVAIL 2.1 mg 30-count box (Drug) $132.68
- RELISTOR ORAL (Drug) $123.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.